John is the CEO of Apton Biosciences. He is a commercial leader and health policy expert with over twenty years of experience in revenue-generating and management roles across the health insurance, healthcare IT, and molecular diagnostics industries. John most recently served as the chief commercial officer of Veracyte, Inc. where he was responsible for the marketing, sales and market-access for a portfolio of innovative molecular diagnostic products. John previously held roles with IBM, Humana Inc., and America’s Health Insurance Plans (AHIP). He received his MBA from University of Miami and BA in Political Science from Hampden-Sydney College.